These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37172903)

  • 21. Analysis of PTEN, estrogen receptor α and progesterone receptor expression in endometrial hyperplasia using tissue microarray.
    Pieczyńska B; Wojtylak S; Zawrocki A; Biernat W
    Pol J Pathol; 2011 Sep; 62(3):133-8. PubMed ID: 22102068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized endometrial proliferations associated with pregnancy: clinical and histopathologic features of 11 cases.
    Genest DR; Brodsky G; Lage JA
    Hum Pathol; 1995 Nov; 26(11):1233-40. PubMed ID: 7590698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions.
    Norimatsu Y; Miyamoto T; Kobayashi TK; Oda T; Moriya T; Yanoh K; Miyake Y; Ohno E
    Diagn Cytopathol; 2008 Apr; 36(4):216-23. PubMed ID: 18335551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.
    Ip PP
    Virchows Arch; 2018 Jun; 472(6):907-917. PubMed ID: 29445890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.
    Zannoni GF; Santoro A; Angelico G; Spadola S; Arciuolo D; Valente M; Inzani F; Pettinato A; Vatrano S; Fanfani F; Scambia G; Fraggetta F
    Hum Pathol; 2019 Oct; 92():10-17. PubMed ID: 31269413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Russo M; Newell JM; Budurlean L; Houser KR; Sheldon K; Kesterson J; Phaeton R; Hossler C; Rosenberg J; DeGraff D; Shuman L; Broach JR; Warrick JI
    Cancer; 2020 Jun; 126(12):2775-2783. PubMed ID: 32187665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
    Nucci MR; Prasad CJ; Crum CP; Mutter GL
    Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of Endometrial Carcinoma.
    Lax SF
    Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
    Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
    Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposite Prognostic Impact of Single PTEN-loss and
    Lazaridis G; Kotoula V; Vrettou E; Kostopoulos I; Manousou K; Papadopoulou K; Giannoulatou E; Bobos M; Sotiropoulou M; Pentheroudakis G; Efstratiou I; Papoudou-Bai A; Psyrri A; Christodoulou C; Gogas H; Koutras A; Timotheadou E; Pectasides D; Zagouri F; Fountzilas G
    Cancer Genomics Proteomics; 2019; 16(3):195-206. PubMed ID: 31018950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
    Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
    Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
    Aoun BA; Skala SL
    Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
    Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.
    Dong Y; Yang X; Wong O; Zhang X; Liang Y; Zhang Y; Wong W; Nong L; Liao Q; Li T
    Hum Pathol; 2012 Aug; 43(8):1197-205. PubMed ID: 22209294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.